Guillain-Barre syndrome (GBS) is defined clinically as a peripheral ne
uropathy causing limb weakness that progresses for up to 4 weeks befor
e reaching a plateau. The symptoms may be caused by inflammatory demye
lination, axonal degeneration, or both. GBS occurs throughout the worl
d, with a median incidence of 1.3 cases/100,000 population (range, 0.4
-4.0). Males are more commonly affected than females, and there are pe
aks in young adults and the elderly. Theres no clear seasonal associat
ion in Western countries, although this may be because the most freque
nt antecedent events, respiratory and enteric infections, have opposit
e seasonality. The most frequently identified cause of GBS is Campylob
acter jejuni infection, which has been identified in up to 41% of pati
ents and is associated with more severe disease and prolonged disabili
ty. Summer epidemics of GBS occur among children and young adults in N
orthern China and are particularly likely to be associated with C. jej
uni infection.